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Liver Resection for Hepatic Adenoma 
Richard Weil III, MD; Lawrence J. Koep, MD; Thomas E. Starzl, MD 
• Between 1970 and 1978, eight hepatic adenomas were 
resected. Four of the eight patients took oral contraceptive pills 
before the hepatic adenoma was Identified; one pallent was 
male. Four patients had evidence of bleeding at the time of 
presentation. The original histologic diagnosis In the first five 
patients was malignant hepatoma. There has been no known 
recurrence of tumor and all patients are well. The use 01 oral 
contraceptives In these patients has been prohibited. Formal 
anatomic resection Is recommended lor hepatic adenoma when 
this procedure can be done without mortality or serious morbid· 
Ity; however, In the future, less drastic treatments, such as 
occlusion of the hepatic arterial circulation to the tumor or 
discontinuation of oral contraceptives, may prove as effective as 
tumor resection. 
(Arch Surg 114:178·180, 1979) 
During the eight-year period 1970 to 1978, eight patients 
with hepatic adenoma have been treated on the 
surgical service of the University of Colorado Medical 
Center, Denver. They are the subject of this report. 
SUBJECTS AND METHODS 
Seven of the eight patients who were treated for hepatic 
adenomas between 1970 and June 1978 were female, and one was 
male (Table). Their ages at the time of operation ranged from 16 
to 30 years. Six had fever as one of the presenting symptoms, six 
had abdominal pain, and three had palpable upper abdominal 
masses. One patient (case 6) was found to have gallstones and 
underwent her first operation elsewhere for presumed subacute 
cholecystitis; four additional patients (cases 3, 4, 5, and 8) under-
went diagnostic laparotomies at other hospitals before the hepatic 
tumor was discovered. In two patients (cases 4 and 8), there was 
bleeding into the tumor preoperatively, with associated anemia; in 
two patients (cases 1 and 2), there was intraperitoneal hemorrhage 
and hypovolemic shock. Two patients had protracted diarrhea 
(cases 1 and 5) that was thought due to amebic colitis in one 
Accepted for publication Sept 6. 1978. 
From the Department of Surgery. University of Colorado Medical Center, 
Denver. and the Denver Veterans Administration Hospital 
Reprint requests to University of Colorado Medical Center. 4200 E Ninth 
Ave. Denver. CO 8)262 (Dr Weill. 
178 Arch Surg-Vol 114. Feb 1979 
patient, whose home was in Mexico . 
A history of oral contraceptive use prior to operation was 
elicited in four of the seven female patients, for durations of a few 
months to eight years. As far as we know, the single male patient 
had never taken androgens of any kind. 
Radionuclide hepatography and hepatic angiography were done 
in some of the patients prior to transfer to Denver. In one patient 
(case 5) whose angiography was done in Denver, the findings were 
considered most consistent with malignant hepatoma. 
In all patients, the tumor was single, rather than multicentric 
grossly and the tumor in all cases was greater than 10 cm in 
diameter. All eight patients were treated by Jormal hepatic;. 
resection: right hepatic lobectomy in four cases, trisegmentectomy 
(extended right lobectomy) in three, and left lobectomy in one. 
RESULTS 
In the first two patients, subphrenic abscesses developed 
following operation; there have been no postoperative 
complications in the six patients operated on during the 
last seven years. The initial histologic interpretation of the 
resected tumors was malignant hepatoma in the first five 
cases. The first two patients were each given fluorouracil 
chemotherapy for approximately three years following 
operation. In 1974, the first five cases were reviewed and in 
all cases, the revised diagnosis was hepatic adenoma. The 
initial histologic diagnosis in the last three Denver cases 
was hepatic adenoma. 
None of the patients have taken oral contraceptive pills 
since operation. None are known to have recurrent tumor 
and all are well one-half to eight years after resection of 
their tumors. 
COMMENT 
In a recent review of solid liver tumors,' 323 of the 621 
collected cases were primary liver tumors and 111 (34%) 
were benign; the records were reviewed from 127 patients 
at least 16 years of age who had undergone resections of 
primary liver tumors in 49 hospitals. Histologic review of 
119 of these 127 patients resulted in reclassifying nine 
cases originally called malignant hepatoma as hepatic 
adenoma. The authors of this review commented that in no 
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Clinical-Pathologic Findings in Eight Patients With Hepatic Adenoma 
Patlentl Year 
Age, yrl of initial 
s.. Operation S,mptoms and Signs 
1/27/F 1970 Fever, vomiting, jaundice, diarrhea, 
anemia, shock 
2/25/F 1970 Acute abdomen, anemia, shock 
3/25/M 1971 Fever, epigastric pain 
4/19/F 1972 Fever, fight upper quadrant pain, 
mass, anemia 
5/29/F 1974 Fever, right upper quadrant mass, 
diarrhea 
6/30/F 1975 Fever, right upper quadrant pain, 
gallstones 
7/16/F 1975 Fever, right upper quadrant pain 
8/19/F 1977 Right upper quadrant mass, anemia 
area of liver tumors is there more controversy concerning 
classification than in the area of benign liver tumors. 
Although Edmondson,' Ishak and Rabin,J and Kay and 
Schatzhi< have described the histology and ultrastructural 
characteristics of the hepatic adenoma, and although in 
fact Edmondson's 1958 classification' is still very satisfac-
tory, there has been chronic misunderstanding of this 
material and corresponding difficulty with nomencla-
ture.'" The initial misdiagnosis of our first five cases as 
malignant hepatomas, rather than hepatic adenomas. is 
clearly not unique. 
Although the hepatic adenoma was observed prior to the 
introduction of oral contraceptives in 1960,' the apparent 
increase in recognition of this tumor in recent years has 
suggested that oral contraceptives may have a part in the 
natural history of the hepatic adenoma. In 1973, Baum et 
al" suggested that the development of benign liver tumors 
might be caused by the use of oral contraceptiv~ pills and 
since then, there have been many reports concerning a 
possible relationship between oral contraceptives and 
hepatic adenoma,"'" focal nodular hyperplasia,"".1'" and 
malignant hepatoma.'" On the other hand. Guzman et all> 
have pointed out that the association described by Baum 
and co-workers is not found in all series of cases; in fact, 
only three of ten patients of Guzman et al having hepatic 
adenomas had taken oral contraceptives before the devel-
opment of their tumors. Four of our eight patients had a 
negative "pill" history. On the other hand, the reports of 
tumor regression following discontinuation of oral contra-
ceptives,u.IJ, •. 2o and tumor recurrence in two patients who 
continued oral contraceptives after apparently complete 
resections of the primary tumors" would argue for a 
promoting role of oral contraceptives, Edmondson et al" 
have suggested estrogens, particularly mestranol, rather 
than progesterones as the major tumor promoter, but this 
concept remains controversial. 
Four of the eight Denver patients had fever and upper 
abdominal pain as the main presenting symptoms. One of 
our patients had gallstones (case 6) and was initially 
operated at another hospital for that problem, but none of 
the other seven patients were originally thought to have 
cholecystitis, although cholecystitis was part of the differ-
ential diagnosis in the early phases of l'valuating most of 
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Oral Contraceptive Original 
History Histologic 
Preoperatlvel, Operation Dlagnos's 
1964 to 1970 Right lobectomy Hepatoma 
Unknown Trisegmentectomy Hepatoma 
Left lobectomy Hepatoma 
None Trisegmentectomy Hepatoma 
Intermittent 1966 to 1974 Right lobectomy Hepatoma 
20 months (1966 to 1969) Right lobectomy Adenoma 
None Trisegmentectomy Adenoma 
Intermittent 1975 to 1976 Right lobectomy Adenoma 
these patients. 
Four of our patients (cases 1, 2, 4, and 8) had evidence of 
bleeding into the tumor or peritoneal cavity and at least 
two of these patients had previously taken oral contracep-
tives; the contraceptive history is not known in one of 
these patients (case I), It has been suggested that oral 
contraceptives may increase the frequency of bleeding in 
the hepatic adenoma"; the fact that only two of eight 
patients (25%) hemorrhaged from the tumor into the free 
peritoneal cavity (cases 1 and 2) is a lower frequency of 
hemorrhage than has been observed in some other 
series!'''' ".,. 
Exploratory laparotomy was done at other hospitals in 
five of our eight patients, resulting in the diagnosis of 
hepatic tumor. In two of these patients, the wound was 
. infected at the time of reoperation for tumor resection in 
Denver; one patient underwent trisegmentectomy (case 4) 
and the other patient, right lobectomy (case 6), both with 
wide dramage, and neither had postoperative infections. 
In our first patient, needle biopsy of the liver was done 
at another hospital for diagnosis and the biopsy specimen 
was interpreted as consistent with mild hepatitis. The 
question of needle biopsy for diagnosis of hepatic adeno-
mas has been recently reviewed by Terblanche,'" and he 
agreed with the suggestion of Edmondson et ai" that this 
procedure may not be so likely to cause hemorrhage as was 
originally feared. Nevertheless, a skilled and experienced. 
surgical pathologist is needed if the needle biopsy is to.' 
have any real diagnostic value. 
The central question in treating patients with hepatic 
adenoma is whether withdrawal of oral contraceptives is 
sufficient treatment for those patients who are taking 
such medication, or whether destruction of the tumor is 
necessary. In patients with no history of oral contraceptive 
ingestion, destruction of the tumor is the only therapeutic 
option other than observation in the hope of spontaneous 
tumor regression. 
Although some hepatic adenomas will involute following 
\\;thdrawal of oral contraceptive hormones"o.II.IJ,.., •. 17.Z0 
removal of the tumor provides the most definitive therapy, 
if removal can be done without significant morbidity or 
mortality, Hemoval eliminates concern about the possibili-
ty of obsel\'ing a malignant tumor that has been incorrect-
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Iy diag-nosed as benig-n and removal of the tumor elimi-
nates the risk of hemorrhag-e from the tumor during a 
period of observation. 
If the patient with hepatic adenoma has symptoms or 
signs of hemorrhag-c, mechanical control of the bleeding is 
urgently or emergentl:.' needed to save the patient's life. 
Terblanche'" has sug-g-ested laparotomy, frozen section 
diagnosis of the tumor, and Jig-ation of either the right or 
left hepatic artery as the initial treatment of the patient 
with active hemorrhag-e into the peritoneal cayDit~·: he ha" 
suggested radiolog-ic embolization of the hepatic artery for 
the patient with estahlished diag-nosis and pain without 
evidence of life-threatenIng- hemorrhag-e. 
The eight major anatomie resections during- an eight-
year period in Denver were carried out using techniques 
that have been described previously." There was no 
mortality. no serious morbidity, and there is no known 
recurrence of tumor. At the present time, formal anatomic 
resection of the benign hepatic adenoma is recommended 
as the preferred treatment, regardless of the manner of 
presentation of this tumor, when such resection can be 
carried out without mortality or sig-nificant morbidity. 
However. in the future. less drastic ways of treating these 
tumors, including angiographir embolization, hepatic 
artery ligation, enucleation of the tumor. and discontinu-
ing oral contraceptives, may prove to be as effective as 
anatomic hepatic resection. Oral contraceptive medications 
should be permanently prohibited in all patients with 
hepatic adenomas. 
This study was supported hy research "rants MRIS RlIR-OI and 7227-01 
from the Veterans Administration. "rants AM-17260 and AM-07772 from 
the National Institutes of Health, and "rants RR-00051 and RR-00069 from 
the General Clinic I\esearch Centers Program of the Division of Research 
Resources, National I nstitutes of Health. The first five cases W(!TC reviewed 
by Hu"h Edmondson, MD, Los Angeles. and Robert H. Fennel, MD. 
Denver. 
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